APA (7th ed.) Citation

Tillmann, A., Stillenmunkes, R., Garweg, J. G., Cattaneo, J., Bartolomeo, N., Grimaldi, G., . . . Eandi, C. (2025). One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report. Ophthalmology & Therapy, 14(12), 3079. https://doi.org/10.1007/s40123-025-01252-6

Chicago Style (17th ed.) Citation

Tillmann, Anne, et al. "One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report." Ophthalmology & Therapy 14, no. 12 (2025): 3079. https://doi.org/10.1007/s40123-025-01252-6.

MLA (9th ed.) Citation

Tillmann, Anne, et al. "One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report." Ophthalmology & Therapy, vol. 14, no. 12, 2025, p. 3079, https://doi.org/10.1007/s40123-025-01252-6.